NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $222,000 | -10.1% | 2,927 | +37.6% | 0.03% | +52.4% |
| Q3 2021 | $247,000 | -47.7% | 2,127 | 0.0% | 0.02% | -46.2% |
| Q2 2021 | $472,000 | +123.7% | 2,127 | +32.9% | 0.04% | +116.7% |
| Q1 2021 | $211,000 | -23.8% | 1,600 | 0.0% | 0.02% | -35.7% |
| Q4 2020 | $277,000 | – | 1,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 115,479 | $7,302,000 | 11.05% |
| HARTLINE INVESTMENT CORP/ | 335,585 | $21,219,000 | 5.07% |
| Darsana Capital Partners LP | 1,500,000 | $94,845,000 | 3.08% |
| Rhenman & Partners Asset Management AB | 365,899 | $23,136,000 | 2.55% |
| COURAGE CAPITAL MANAGEMENT LLC | 20,000 | $1,265,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 46,599 | $2,946,000 | 2.04% |
| Granite Investment Partners, LLC | 411,659 | $26,029,000 | 1.40% |
| Nicholas Investment Partners, LP | 146,106 | $9,238,000 | 0.85% |
| Baillie Gifford | 8,829,449 | $558,287,000 | 0.59% |
| Empowered Funds, LLC | 20,936 | $1,324,000 | 0.55% |